Additionally, in p53-mutated tumors, higher CDK6 expression was significantly associated with poorer breast cancer-specific survival (Supplementary Fig. 11E), whereas no such association was observed in p53 wild-type tumors (Supplementary Fig. 11F). This evidence concerns the gene CDK6 and breast carcinoma.